Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis

Parasitology Research

Volumn 90, Issue 1, 2003, Pages 71-79

  Nok, Andrew Jonathan ^a  

^a AHMADU BELLO UNIVERSITY   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY; ANTITRYPANOSOMAL AGENT; ARSENIC OXIDE; CHLORPROMAZINE DERIVATIVE; DIAMINAZINE; DIMERCAPROL; GERMIN; MELAMINE; MELARSAMINE; MELARSEN; MELARSENOXIDE; MELARSOPROL; MORANY; ORGANOARSENIC DERIVATIVE; PENTAMIDINE MESYLATE; PHENYLARSEN; PUROMYCIN; QUINAPYRAMINE; SURAMIN; TRYPANOSOMA VACCINE; TRYPARSAMIDE; UNCLASSIFIED DRUG;

AFRICAN TRYPANOSOMIASIS; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; CEREBROSPINAL FLUID; DIABETES MELLITUS; DIARRHEA; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; FEVER; HUMAN; HYPOTENSION; NEPHROTOXICITY; POLYNEUROPATHY; PRIORITY JOURNAL; SEIZURE; SKIN MANIFESTATION; TRYPANOSOMA BRUCEI;

PROTOZOA; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 0038630951     PISSN: 09320113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00436-002-0799-9     Document Type: Article

References (61)

1. Barret MP (2000) Problems for the chemotherapy of human African trypanosomiasis. Curr Opin Infect Dis 13:647-651
2. Barret MP, Fairlamb AH (1999) The biochemical basis of arsenical-diamidine cross resistance in African trypanosomes. Parasitol Today 15:136-140
3. Basselin M, Lawrence F, Robert-Gero M (1997) Polyamine and pentamidine metabolism in African trypanosomes. Acta Trop 54:215-224
4. Basselin M, Coombs GH, Barret MP (2000) Putrecine and spermidine transport in Leishmania. Mol. Biochem Parasitol 109:37-46
5. Berger BJ, Carter NS, Fairlamb AH (1993) Characterization of Pentamidine-resistant. T. b. brucei. Mol Biochem Parasitol 69:289
6. Berger BJ, Carter NS, Fairlamb AH (1995) Characterization of Pentamidine-resistant T. b. brucei. Mol Biochem Parasitol 69:289-298
7. Bitonti AJ, Dumont JA, McCann PP (1986) Characterization of T. b. brucei S-adenosyl methionine decarboxylase and its inhibition by berenil, pentamidine, methylglyoxal (bis guynylhydrazone). Biochem J 237:685-689
8. Bronner U, Douoa F, Ericsson O, Gustafsson LL, Miezan TW, Rais M (1991) Pentamidine concentrations in plasma, whole blood, and cerebrospinal fluid during treatment of T. b. gambiense infection in Cote d'Ivoire. Trans R Soc Trop Med Hyg 85:608-611
9. Brown MS, Kovanen DT, Goldstein JL (1980) Evolution of the LDL receptor concept from cultured cells to intact animals. Ann N Y Acad Sci 348:48-67
10. Burri C, Keiser J (2001) Pharmacokinetic investigations in patients from Northern Angola refractory to melarsoprol treatment. Trop Med Int Health 6:412-420
11. Burri C, Baltz T, Girond C, Doua F, Welker HA, Brun R (1993) Pharmacokinetic properties of the trypanocidal drug Melarsoprol. Chemotherapy 39:225-234
12. Burri C, Nkunku S, Merolle A, Smith T, Blum J, Brun T (2000) Efficacy of a new, concise schedule for melarsoprol in treatment of sleeping sickness caused by T. b. gambiense: a randomised trial. Lancet 355:1419-1425
13. Cater NS, Fairlamb AH (1993) Arsenical resistant trypanosome lack the unusual adenosine transporter. Nature 361:173-175
14. Cater NS, Berger BJ, Fairlamb AH (1995) Uptake of diaimine drugs by the P2 nucleoside transporter in melarsen sensitive and resistant T. b. brucei. J Biol Chemistry 270:28153-28157
15. Collins JM, Klecker RW, Yarchoan R, Lane HC, Fauci AS, Redfield RR, Broder S, Meyers CE (1986) Clinical pharmacokinetics of suramin in patients with HTLV-III/LAV infection. J Clin Pharmacol 26:22-26
16. Damper D, Patton CL (1976) Pentamidine transport and sensitivity in brucei group trypanosomes. J Protozool 23:349-356
17. De Clercq E(1979) Suramin: a potent inhibitor of reverse transcriptase of RNA tumor viruses. Cancer Lett 8:9-22
18. De Koning HD (2001) Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol 31:512-522
19. De Koning HP, Jarvis SM (1999) Purine transporters in blood stream forms of T. brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol Pharmacol 56:1162-1170.
20. Dixon H, Ginger CD, Williamson J (1971) The lipid metabolism of blood and culture forms of T. lewisi and T. rhodesiense. Comp Biochem Physiol 39B:247-266
21. Doua F, Miezan TW, Sanan Singaro JR, Boa YF, Baltz T (1996) The efficacy of pentamidine in the treatment of early stage T. b. gambiense trypanosomiasis. Am J Trop Med.Hyg 55:586-588
22. Ericsson O, Schweda E, Bronner V, Rombo L, Frieden M, Gustafsson LL (1997) Determination of melarsoprol in biological fluids by high performance liquid chromatography and characterization of stereoisomers by nuclear magnetic resonance spectroscopy. J Chromatogr B Biomed Sci App 690:243-251
23. Feuillan P, Raffeld M, Stein CA, Lipford N, Rehaquist D, Meyers CE, LaRocca RV, Chrousos GP (1987) Effects of suramin on function and structure of adrenal cortex in cynomolgus monkey. J Clin Endocrinol Metab 65:153-158
24. Friedheim EAH (1949) MelB in the treatment of human trypanosomiasis. Am J Trop Med Hyg 29:173-180
25. Goldstein JL, Anderson RGW, Brown MSL (1979) Coated pits, coated vesicles and receptor mediated endocytosis. Nature 279:679-685
26. Gutteridge WE (1969) Some effects of pentamidine diisothionate on Crithridia fasiculata. J Protozool 16:306-311
27. Harder A, Greif G, Haberkorn A (2001) Chemotherapeutic approaches to protozoa: Kinetoplastida - current knowledge and outlook. Parasitol Res 87:778-80
28. Hawking F (1940) Concentration of Bayer 205 (Germanin) in human blood and cerebrospinal fluid after treatment. Trans R Soc Trop Med Hyg 34:37-52
29. Hawking F (1978) Suramin with special reference to onchocerciasis. Adv Pharmacol Chemother 15:289-322
30. Hunter CA, Jennings FW, Adams JH, Murray M, Kenedy PGE (1992) Subcurative chemotherapy and fatal post-trearment reactive encephalopathies in African trypanosomes. Lancet 339:956-958
31. Kaminsky R, Mäser P (2000) Drug resistance in African trypanosomes. Curr Opin Anti-infect Invest Drugs 2:76-82
32. Keiser J, Ericsson O, Burri C (2000) Investigations of the metabolites of the trypanocidal drug Melarsoprol. Clin Pharmacol Ther 67:478-488
33. Kimura H, Meguro T, Badr A, Zhang JH (2002) Suramin induced reversal of chronic cerebral vacospasm in experimental subarachroid hemmorhage. J Neurosurg 97:129-135
34. Kuzoe FAS (1993) Current situation of African trypanosomiasis. Acta Trop 54:153-162
35. Legros D, Evans S, Maiso F, Enyaru JCK, Mbulamberi D (1999) Risk factors for the treatment failures after melarsoprol for T. b. gambiense trypanosomiasis in Uganda. Trans R Soc Trop Med Hyg 93:439-442
36. Maes L, Vandeveken M, Hamers R, Doua F, Cattand P (1988) The monitoring of trypanocidal treatment with a sensitive ELISA method measuring melarsoprol levels in serum and CSF. Ann Soc Belg Med Trop 68:219-231
37. Mahley RW, Innerarity TL, Pitas RE, Weisgraber KH, Brown JH, Gross E (1977) Inhibition of the lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in B apo proteins. J Biol Chem 252:7279-7287
38. Matovu E, Geiser F, Schneider V, Mäser P, Enyaru JC, Kamisnsky R, Gallati S, Seebeck T (2001a) Structural formula of suramin. Mol Biochem Parasitol 117:73-81
39. Matovu E, Enyaru JCK, Schmid C, Seebeck T,Kaminsky R (2001b) Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health 6:497-411
40. Mbati PA, Hirumi K, Inoue N,Situakibanza NH, Hirumi H (2000) Suggested dosage rates of melarsoprol in the treatment of mice experimentally infected with T. b. gambiense. Onderstepoort J Vet Res 6:71-74
41. Misset O, Opperdoes FR (1987) The phosphoglycerate kinases from T. brucei, a comparison of the glycosomal and cytosolic isozyme and their selectivity towards suramin. Eur J Biochem 162:493-500
42. Misset O, Bos OJM, Opperdoes FR (1986) Glycolytic enzymes of Trypanosoma brucei simultaneous purification, intraglycosomal concentration and physical properties. Eur J Biochem 157:441-453
43. Nun CM, Neide S (1995) Sequence dependent drug binding to the minor groove of DNA crystal structure of DNA dodecamer d(cgcaaatttgcg)2 complexed with propamidine. J Med Chem 38:2317-2325
44. Onyango RJ, Ogada T, Mwabi D (1968) The use of MelB in the treatment of T. b. rhodesiense sleeping sickness. EATRO Rep 82:3
45. Opperdoes FR, Coppens I, Baudhuin P (1987) Digestive enzymes receptor mediated endocytosis and their role in the nutrition of blood stream trypanosomes. In: Chang K-P, Snary D (eds) Host parasite cellular and molecular interaction in protozoal infection.) Springer, Berlin Heidelberg New York, pp 51-66
46. Park BK, Kitterungham NR (1996) Drug protein conjugation and its immunological consequences. Drug Metab Rev 22:87-144
47. Pepin J, Milord F (1994) The treatment of human African trypanosomiasis. Adv Parasitol 33:1-47
48. Sands M, Kron MA, Brown RB (1985) Pentamidine, a review. Rev Infect Dis 7:625-634
49. Schneider WJ, Beisiegel U, Goldstein JL, Brown MS (1982) Purification of low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J Biol Chem 257:2664-2673
50. Scott AG, Tait A, Turner CMR (1996a) T. brucei lack of cross resistance to melarsoprol in vitro by Cymelarsen-resistant parasites. Exp Parasitol 86:181-90
51. Scott AG, Tait A, Turner CMR (1996b) Characterization of cloned lines of T. brucei expressing stable resistance to MelCy and suramin. Acta Trop 60:251-262
52. Shahi SK, Krauth-Siegel RL, Clayton CE (2002) Overexpression of the putative thiol conjugate transporter TbMRPA causes melarsoprol resistance. Mol Microbiol 43:1129-1138
53. Shapiro TA (1993) Inhibition of topoisomerases in African trypanosomes. Acta Trop 54:251-260
54. Soignet SL, Tong WP, Hirschfeld S, Warrell RPJr (1999) Clinical study of an organic arsenical, melarsoprol in patients with advanced leukemias. Cancer Chemother Pharmacol 44:417-421
55. Vansterkenurg ELM, Coppens I, Wilting J, Bos OJM, Fischer MJE, Janssen LHM, Opperdoes FR (1993). The uptake of trypanocidal drug suramin in combination with LDL by T. brucei and its possible mode of action. Acta Trop 54:237-250
56. Voogd TE, Vansterkenurg ELM, Wilting J, Jansen LHM (1993) Recent research on biological activity of suramin. Pharmacol Rev 45:177-203
57. Waalker TP, Devita VT (1970) The determination of pentamidine (4,4-diaamidinophenoxypentane) in plasma, urine and tissues. J Lab Clin Med 75:871-878
58. Wierenge RK, Swinleels B, Mitchels PAM, Osinga K, Misste O, VanBeenmen J, Gibson WC, Postua JPM, Borst P, Opperdoes FR, Wol WGS (1987). Common elements in the surface of glycolytic enzymes from T. brucei may serve as topogenic signals for import glycosomes. EMBO J 6:215-221
59. Williamson M, Calleus M, Kunzt D, Perie J, Opperdoes FR (1993). Synthesis and activity of inhibitors highly specific for glycolytic enzymes from T. brucei: Mol Biochem Parasitol 59:201-210
60. Wood DH, Hall JE, Rose BG, Tidwell RR (1998) 1,5-Bis(4-amidinophenoxypentane) pentamidine is a potent inhibitor of H3-diazoxan binding to imidazole I2 binding sites. Eur J Pharmacol 353:97-103
61. Zhang ZQ, Baltz T (1991) In vivo and in vitro sensitivity of T. evansi and T. equiperdum to diamine, suramin, MelCy, quinapyramine and isometamidium. Acta Trop 50:101-110